Literature DB >> 2351811

Physicians' perceptions about increased glove-wearing in response to risk of HIV infection.

L S Linn1, K L Kahn, B Leake.   

Abstract

Glove-wearing attitudes of 375 physicians, representing 56% of all physicians surveyed, were ascertained. Although the majority were comfortable with their current glove use, 33% preferred wearing them more frequently. The most common reasons for not wearing gloves were a low likelihood of disease transmission and fear of offending patients. Many physicians felt that more frequent glove use in examining human immunodeficiency virus- (HIV)-positive patients might reduce rapport and diminish the adequacy of physical examination procedures, but only 11% felt that increased glove use would compromise overall care of HIV-positive patients. With regard to all patients, 33% felt that increased glove use in examinations would compromise care. Additionally, 56% of physicians stated that they were somewhat concerned about HIV infection. Glove-wearing preferences were significantly associated with greater concern about infection, a younger age and more frequent exposure to blood and body secretions. Contact with high-risk patient groups was not associated with glove-wearing preferences.

Entities:  

Mesh:

Year:  1990        PMID: 2351811     DOI: 10.1086/646162

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  2 in total

1.  Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach.

Authors:  Annalee Yassi; David Moore; J Mark Fitzgerald; Philip Bigelow; Chun-Yip Hon; Elizabeth Bryce
Journal:  J Occup Environ Med       Date:  2005-01       Impact factor: 2.162

Review 2.  Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines.

Authors:  David Moore; Bruce Gamage; Elizabeth Bryce; Ray Copes; Annalee Yassi
Journal:  Am J Infect Control       Date:  2005-03       Impact factor: 2.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.